These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Photodynamic efficiency of macrophage activity using a photosensitizer, lumin, with near-IR laser light for photoimmunotherapy of a cancer.
    Author: Mito K.
    Journal: Front Med Biol Eng; 1996; 7(2):81-92. PubMed ID: 8803558.
    Abstract:
    This study was carried out to determine the efficacy of photoimmunotherapy using a photosensitizer, lumin, and near-IR laser light irradiation for cancer therapy. Lumin is a potent cell-activating agent and a photosensitizer characterized by typical absorption peaks at 670 and 770 nm. To clarify that ingestion activity is enhanced by lumin administration with different light irradiation, He-Ne laser light (632.8 nm) and near-IR laser light (780 nm) were used. The results showed that a small dose of lumin (5 ng/ml) with near-IR laser light dramatically enhanced the ingestion activity. A human lung cancer grafted onto nude mice was used in this study. After the tumor hypertrophied, lumin was injected into it six times. Then, it was exposed to near-IR laser light (2 mW, 1 min) every other day for 2 weeks. The whole tumor was strongly cicatrized by collagen fiber from the stroma. It was removed 15 weeks after the treatment. Immunological function was investigated using a two-color flow cytometric assay method based on immunofluorescence labeling with specific monoclonal antibodies of 10(4) cell samples harvested from mouse peripheral blood. At 40 weeks, the ratio of T cells to B cells in untreated mice was 0.23, whereas that in treated mice was 0.58. These results demonstrated that photoimmunotherapy with lumin administration and laser light irradiation is a reliable method of cancer therapy.
    [Abstract] [Full Text] [Related] [New Search]